Skip to Content

'
Constance T. Albarracin, M.D., Ph.D.

Present Title & Affiliation

Primary Appointment

Associate Professor, Department of Pathology, Division of Pathology/Lab Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX

Education & Training

Degree-Granting Education

1993 University of Illinois, Chicago, IL, PHD, Physiology
1984 University of Santo Tomas, Manila, Philippines, MD, Medicine

Experience/Service

Other Appointments/Responsibilities

Affiliate Faculty, The University of Texas MD Anderson Cancer Center Clinical Cancer Genetics, Houston, TX, 2007-present

Grant & Contract Support

Title: Impact of ErbB2 and RB pathways on DCIS progression and treatment
Funding Source: NIH/NCI
Role: Collaborator
Principal Investigator: Agnes Witkiewicz
Duration: 7/1/2012 - 6/30/2017
 
Title: Protein Signaling Network in ER negative Breast cancer between AA and CA
Funding Source: NIH/NCI
Role: Consultant
Principal Investigator: Peng Lee
Duration: 2012
 
Title: DNA Damage As A Biomarker Of Risk Of Breast Cancer
Funding Source: UTMDACC IPCT
Role: Collaborator
Principal Investigator: Dr. Abenaa Brewster
Duration: 2012
 
Title: Serum MicroRNAs To Assess Breast Cancer Progression In BRCA and High Risk Patients
Funding Source: DOD/Congressionally Directed Medical Research Programs (DOD/CDMRP)
Role: Collaborator
Principal Investigator: Banu Arun
Duration: 2012
 
Title: Androgen receptor coactivator p44/Mep50 in breast cancer
Funding Source: Department of Defense (DOD)
Role: Consultant
Duration: 2011
 
Title: CDK Inhibition and Smad3 Tumor Suppression in Aggressive Breast Cancer Subtypes
Funding Source: NIH/NCI
Role: Co-Principal Investigator
Principal Investigator: Jaqueline Jeruss
Duration: 2011
 
Title: Oncogene activation of DNA damage response as a biomarker of breast cancer risk and possible target for prevention
Funding Source: American Society of Clinical Oncology (ASCO)
Role: Co-Investigator
Principal Investigator: Isabelle Bedrosian
Duration: 7/1/2010 - 6/30/2013
 
Title: Role of MicroRNA of the Annexin A1 Pathway in Breast Cancer Progression
Funding Source: Susan G. Komen Breast Cancer Foundation
Role: Principal Investigator
Duration: 5/1/2010 - 4/30/2013
 
Title: Aberrant Expression Of Mir-196 Targets Annexin A1 In In Situ And Invasive Breast Carcinomas: Potential Role In Breast Cancer Progression.
Funding Source: American Cancer Society (ACS)
Role: Principal Investigator
Duration: 2010
 
Title: DCIS Collaborative Consortium
Funding Source: University of California, San Francisco
Role: Collaborator
Duration: 9/30/2009 - 9/29/2011
 
Title: Germline Mutation Of NHERF 2 and Its Network Genes In Hereditary Breast Cancer
Funding Source: NIH/NCI
Role: Collaborator
Principal Investigator: Jiale Dai
Duration: 2009 - 2012
 
Title: Role Of MicroRNAs In Endometrial Cancer
Funding Source: NIH/NCI
Role: Principal Investigator
Duration: 2009 - 2012
 
Title: Detection Of High Risk In Preneoplastic and Preinvasive Lesions of Breast Cancer
Funding Source: NIH/NCI
Role: Principal Investigator
Duration: 2009 - 2012
 
Title: Early Markers Of High Risk In Premalignant Lesions Of Breast: Annexin A1 and MicroRNAs
Funding Source: Avon Foundation Breast Cancer Research Program
Role: Principal Investigator
Duration: 2009 - 2011

Last updated: 12/9/2013